nodes	percent_of_prediction	percent_of_DWPC	metapath
Ponatinib—ABCB11—Glyburide—gestational diabetes	0.388	0.572	CbGbCtD
Ponatinib—ABCG2—Glyburide—gestational diabetes	0.185	0.272	CbGbCtD
Ponatinib—ABCB1—Glyburide—gestational diabetes	0.0665	0.098	CbGbCtD
Ponatinib—CYP3A4—Glyburide—gestational diabetes	0.0399	0.0587	CbGbCtD
Ponatinib—KDR—umbilical vein—gestational diabetes	0.00967	0.0726	CbGeAlD
Ponatinib—FGFR4—embryo—gestational diabetes	0.0072	0.0541	CbGeAlD
Ponatinib—FGFR3—embryo—gestational diabetes	0.00491	0.0369	CbGeAlD
Ponatinib—BCR—islet of Langerhans—gestational diabetes	0.0044	0.033	CbGeAlD
Ponatinib—FGFR4—head—gestational diabetes	0.00365	0.0274	CbGeAlD
Ponatinib—RET—embryo—gestational diabetes	0.00339	0.0254	CbGeAlD
Ponatinib—FGFR2—embryo—gestational diabetes	0.00322	0.0242	CbGeAlD
Ponatinib—TEK—embryo—gestational diabetes	0.00308	0.0232	CbGeAlD
Ponatinib—Myelosuppression—Glyburide—gestational diabetes	0.00292	0.14	CcSEcCtD
Ponatinib—BCR—uterus—gestational diabetes	0.00287	0.0215	CbGeAlD
Ponatinib—SRC—islet of Langerhans—gestational diabetes	0.00283	0.0213	CbGeAlD
Ponatinib—BCR—adipose tissue—gestational diabetes	0.0028	0.0211	CbGeAlD
Ponatinib—PDGFRA—embryo—gestational diabetes	0.00279	0.021	CbGeAlD
Ponatinib—SRC—embryo—gestational diabetes	0.00274	0.0206	CbGeAlD
Ponatinib—FGFR1—uterus—gestational diabetes	0.00255	0.0192	CbGeAlD
Ponatinib—KDR—embryo—gestational diabetes	0.00252	0.0189	CbGeAlD
Ponatinib—LYN—head—gestational diabetes	0.0025	0.0188	CbGeAlD
Ponatinib—FGFR1—adipose tissue—gestational diabetes	0.0025	0.0188	CbGeAlD
Ponatinib—FGFR3—head—gestational diabetes	0.00249	0.0187	CbGeAlD
Ponatinib—BCR—vagina—gestational diabetes	0.00233	0.0175	CbGeAlD
Ponatinib—LCK—uterus—gestational diabetes	0.00228	0.0172	CbGeAlD
Ponatinib—KIT—embryo—gestational diabetes	0.00223	0.0168	CbGeAlD
Ponatinib—LCK—adipose tissue—gestational diabetes	0.00223	0.0168	CbGeAlD
Ponatinib—FGFR2—uterus—gestational diabetes	0.00217	0.0163	CbGeAlD
Ponatinib—BCR—head—gestational diabetes	0.00215	0.0162	CbGeAlD
Ponatinib—FGFR2—adipose tissue—gestational diabetes	0.00212	0.0159	CbGeAlD
Ponatinib—TEK—uterus—gestational diabetes	0.00208	0.0156	CbGeAlD
Ponatinib—FGFR1—vagina—gestational diabetes	0.00207	0.0156	CbGeAlD
Ponatinib—TEK—adipose tissue—gestational diabetes	0.00203	0.0153	CbGeAlD
Ponatinib—ABL1—islet of Langerhans—gestational diabetes	0.00201	0.0151	CbGeAlD
Ponatinib—ABL1—embryo—gestational diabetes	0.00194	0.0146	CbGeAlD
Ponatinib—PDGFRA—uterus—gestational diabetes	0.00188	0.0142	CbGeAlD
Ponatinib—LCK—vagina—gestational diabetes	0.00186	0.0139	CbGeAlD
Ponatinib—PDGFRA—adipose tissue—gestational diabetes	0.00184	0.0138	CbGeAlD
Ponatinib—SRC—adipose tissue—gestational diabetes	0.00181	0.0136	CbGeAlD
Ponatinib—RET—head—gestational diabetes	0.00171	0.0129	CbGeAlD
Ponatinib—KDR—uterus—gestational diabetes	0.0017	0.0128	CbGeAlD
Ponatinib—KDR—adipose tissue—gestational diabetes	0.00166	0.0125	CbGeAlD
Ponatinib—FGFR2—head—gestational diabetes	0.00163	0.0122	CbGeAlD
Ponatinib—TEK—head—gestational diabetes	0.00156	0.0117	CbGeAlD
Ponatinib—PDGFRA—vagina—gestational diabetes	0.00153	0.0115	CbGeAlD
Ponatinib—KIT—uterus—gestational diabetes	0.00151	0.0113	CbGeAlD
Ponatinib—KIT—adipose tissue—gestational diabetes	0.00147	0.0111	CbGeAlD
Ponatinib—PDGFRA—head—gestational diabetes	0.00142	0.0106	CbGeAlD
Ponatinib—SRC—head—gestational diabetes	0.00139	0.0104	CbGeAlD
Ponatinib—KDR—vagina—gestational diabetes	0.00138	0.0104	CbGeAlD
Ponatinib—ABL1—uterus—gestational diabetes	0.00131	0.00985	CbGeAlD
Ponatinib—ABL1—adipose tissue—gestational diabetes	0.00128	0.00964	CbGeAlD
Ponatinib—KDR—head—gestational diabetes	0.00128	0.00959	CbGeAlD
Ponatinib—KIT—vagina—gestational diabetes	0.00122	0.0092	CbGeAlD
Ponatinib—CYP3A5—islet of Langerhans—gestational diabetes	0.00118	0.00885	CbGeAlD
Ponatinib—KIT—head—gestational diabetes	0.00113	0.0085	CbGeAlD
Ponatinib—ABL1—vagina—gestational diabetes	0.00107	0.00801	CbGeAlD
Ponatinib—Hyponatraemia—Glyburide—gestational diabetes	0.000998	0.0479	CcSEcCtD
Ponatinib—ABL1—head—gestational diabetes	0.000985	0.0074	CbGeAlD
Ponatinib—Abdominal distension—Glyburide—gestational diabetes	0.000865	0.0415	CcSEcCtD
Ponatinib—Pancreatitis—Glyburide—gestational diabetes	0.000842	0.0405	CcSEcCtD
Ponatinib—ABCG2—uterus—gestational diabetes	0.000827	0.00621	CbGeAlD
Ponatinib—Pancytopenia—Glyburide—gestational diabetes	0.000816	0.0392	CcSEcCtD
Ponatinib—ABCG2—adipose tissue—gestational diabetes	0.000809	0.00608	CbGeAlD
Ponatinib—CYP3A5—adipose tissue—gestational diabetes	0.000751	0.00564	CbGeAlD
Ponatinib—Jaundice—Glyburide—gestational diabetes	0.000747	0.0359	CcSEcCtD
Ponatinib—CYP2C8—vagina—gestational diabetes	0.000691	0.0052	CbGeAlD
Ponatinib—ABCG2—vagina—gestational diabetes	0.000672	0.00505	CbGeAlD
Ponatinib—Visual impairment—Glyburide—gestational diabetes	0.000663	0.0318	CcSEcCtD
Ponatinib—Eye disorder—Glyburide—gestational diabetes	0.000643	0.0309	CcSEcCtD
Ponatinib—ABCB1—islet of Langerhans—gestational diabetes	0.000625	0.0047	CbGeAlD
Ponatinib—CYP3A5—vagina—gestational diabetes	0.000624	0.00469	CbGeAlD
Ponatinib—Alopecia—Glyburide—gestational diabetes	0.000608	0.0292	CcSEcCtD
Ponatinib—ABCB1—embryo—gestational diabetes	0.000605	0.00454	CbGeAlD
Ponatinib—Malnutrition—Glyburide—gestational diabetes	0.000599	0.0287	CcSEcCtD
Ponatinib—Erythema—Glyburide—gestational diabetes	0.000599	0.0287	CcSEcCtD
Ponatinib—Vision blurred—Glyburide—gestational diabetes	0.000564	0.0271	CcSEcCtD
Ponatinib—Anaemia—Glyburide—gestational diabetes	0.000553	0.0266	CcSEcCtD
Ponatinib—Leukopenia—Glyburide—gestational diabetes	0.000536	0.0257	CcSEcCtD
Ponatinib—Arthralgia—Glyburide—gestational diabetes	0.00051	0.0245	CcSEcCtD
Ponatinib—Myalgia—Glyburide—gestational diabetes	0.00051	0.0245	CcSEcCtD
Ponatinib—Oedema—Glyburide—gestational diabetes	0.000488	0.0235	CcSEcCtD
Ponatinib—Nervous system disorder—Glyburide—gestational diabetes	0.000479	0.023	CcSEcCtD
Ponatinib—Thrombocytopenia—Glyburide—gestational diabetes	0.000478	0.023	CcSEcCtD
Ponatinib—Hyperhidrosis—Glyburide—gestational diabetes	0.000472	0.0227	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Glyburide—gestational diabetes	0.000445	0.0214	CcSEcCtD
Ponatinib—Paraesthesia—Glyburide—gestational diabetes	0.000439	0.0211	CcSEcCtD
Ponatinib—Dyspnoea—Glyburide—gestational diabetes	0.000435	0.0209	CcSEcCtD
Ponatinib—Dyspepsia—Glyburide—gestational diabetes	0.00043	0.0207	CcSEcCtD
Ponatinib—CYP2D6—head—gestational diabetes	0.000426	0.0032	CbGeAlD
Ponatinib—Decreased appetite—Glyburide—gestational diabetes	0.000425	0.0204	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Glyburide—gestational diabetes	0.000422	0.0203	CcSEcCtD
Ponatinib—ABCB1—uterus—gestational diabetes	0.000408	0.00306	CbGeAlD
Ponatinib—Gastrointestinal pain—Glyburide—gestational diabetes	0.000399	0.0192	CcSEcCtD
Ponatinib—ABCB1—adipose tissue—gestational diabetes	0.000399	0.003	CbGeAlD
Ponatinib—Abdominal pain—Glyburide—gestational diabetes	0.000386	0.0185	CcSEcCtD
Ponatinib—Asthenia—Glyburide—gestational diabetes	0.00035	0.0168	CcSEcCtD
Ponatinib—Pruritus—Glyburide—gestational diabetes	0.000346	0.0166	CcSEcCtD
Ponatinib—Diarrhoea—Glyburide—gestational diabetes	0.000334	0.0161	CcSEcCtD
Ponatinib—ABCB1—vagina—gestational diabetes	0.000332	0.00249	CbGeAlD
Ponatinib—Vomiting—Glyburide—gestational diabetes	0.000311	0.0149	CcSEcCtD
Ponatinib—Rash—Glyburide—gestational diabetes	0.000308	0.0148	CcSEcCtD
Ponatinib—Dermatitis—Glyburide—gestational diabetes	0.000308	0.0148	CcSEcCtD
Ponatinib—ABCB1—head—gestational diabetes	0.000306	0.0023	CbGeAlD
Ponatinib—Headache—Glyburide—gestational diabetes	0.000306	0.0147	CcSEcCtD
Ponatinib—Nausea—Glyburide—gestational diabetes	0.00029	0.0139	CcSEcCtD
Ponatinib—ABL1—Developmental Biology—GCK—gestational diabetes	0.000187	0.00112	CbGpPWpGaD
Ponatinib—FGFR1—Signaling by EGFR—FGF2—gestational diabetes	0.000187	0.00112	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling by EGFR—FGF2—gestational diabetes	0.000187	0.00112	CbGpPWpGaD
Ponatinib—KDR—Extracellular matrix organization—FGF2—gestational diabetes	0.000186	0.00112	CbGpPWpGaD
Ponatinib—FGFR1—Signaling by EGFR in Cancer—FGF2—gestational diabetes	0.000185	0.00111	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling by EGFR in Cancer—FGF2—gestational diabetes	0.000185	0.00111	CbGpPWpGaD
Ponatinib—LYN—Innate Immune System—MBL2—gestational diabetes	0.000185	0.00111	CbGpPWpGaD
Ponatinib—FGFR1—Signaling by PDGF—FGF2—gestational diabetes	0.000185	0.00111	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling by PDGF—FGF2—gestational diabetes	0.000184	0.0011	CbGpPWpGaD
Ponatinib—KIT—B Cell Activation—FGF2—gestational diabetes	0.000184	0.0011	CbGpPWpGaD
Ponatinib—ABL1—Innate Immune System—MBL2—gestational diabetes	0.000184	0.0011	CbGpPWpGaD
Ponatinib—CYP3A5—Biological oxidations—CYP19A1—gestational diabetes	0.000182	0.00109	CbGpPWpGaD
Ponatinib—CYP3A5—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000179	0.00107	CbGpPWpGaD
Ponatinib—FGFR2—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000179	0.00107	CbGpPWpGaD
Ponatinib—FGFR3—Disease—RBP4—gestational diabetes	0.000178	0.00106	CbGpPWpGaD
Ponatinib—FGFR1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.000178	0.00106	CbGpPWpGaD
Ponatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.000177	0.00106	CbGpPWpGaD
Ponatinib—KIT—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000176	0.00106	CbGpPWpGaD
Ponatinib—FGFR1—Developmental Biology—ADIPOQ—gestational diabetes	0.000176	0.00105	CbGpPWpGaD
Ponatinib—FGFR1—B Cell Activation—FGF2—gestational diabetes	0.000175	0.00105	CbGpPWpGaD
Ponatinib—PDGFRA—B Cell Activation—FGF2—gestational diabetes	0.000174	0.00104	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—MTNR1B—gestational diabetes	0.000173	0.00103	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—RBP4—gestational diabetes	0.000168	0.00101	CbGpPWpGaD
Ponatinib—FGFR1—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000167	0.001	CbGpPWpGaD
Ponatinib—PDGFRA—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000167	0.000999	CbGpPWpGaD
Ponatinib—LYN—Fc epsilon receptor (FCERI) signaling—FGF2—gestational diabetes	0.000166	0.000995	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—GLS2—gestational diabetes	0.000165	0.000989	CbGpPWpGaD
Ponatinib—LCK—Signaling by SCF-KIT—FGF2—gestational diabetes	0.000163	0.000978	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—LEPR—gestational diabetes	0.000162	0.000968	CbGpPWpGaD
Ponatinib—FGFR3—Disease—NAMPT—gestational diabetes	0.000159	0.000955	CbGpPWpGaD
Ponatinib—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000159	0.000954	CbGpPWpGaD
Ponatinib—FGFR3—Disease—GCK—gestational diabetes	0.000158	0.000949	CbGpPWpGaD
Ponatinib—CYP2C8—Biological oxidations—CYP19A1—gestational diabetes	0.000158	0.000944	CbGpPWpGaD
Ponatinib—LCK—Downstream signaling of activated FGFR—FGF2—gestational diabetes	0.000156	0.000936	CbGpPWpGaD
Ponatinib—ABL1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.000156	0.000932	CbGpPWpGaD
Ponatinib—CYP2C8—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000155	0.000931	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—ADIPOQ—gestational diabetes	0.000155	0.000928	CbGpPWpGaD
Ponatinib—FGFR4—Innate Immune System—FGF2—gestational diabetes	0.000155	0.000927	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—ADIPOQ—gestational diabetes	0.000154	0.000923	CbGpPWpGaD
Ponatinib—LCK—Signaling by ERBB4—FGF2—gestational diabetes	0.000154	0.000921	CbGpPWpGaD
Ponatinib—LYN—B Cell Activation—FGF2—gestational diabetes	0.000154	0.000921	CbGpPWpGaD
Ponatinib—LCK—Innate Immune System—MBL2—gestational diabetes	0.000151	0.000908	CbGpPWpGaD
Ponatinib—KDR—Developmental Biology—LEP—gestational diabetes	0.000149	0.00089	CbGpPWpGaD
Ponatinib—FGFR4—Adaptive Immune System—FGF2—gestational diabetes	0.000149	0.00089	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.000148	0.000884	CbGpPWpGaD
Ponatinib—LCK—Downstream signal transduction—FGF2—gestational diabetes	0.000147	0.00088	CbGpPWpGaD
Ponatinib—LCK—Signaling by FGFR—FGF2—gestational diabetes	0.000146	0.000875	CbGpPWpGaD
Ponatinib—LCK—Signaling by ERBB2—FGF2—gestational diabetes	0.000145	0.000871	CbGpPWpGaD
Ponatinib—LCK—DAP12 signaling—FGF2—gestational diabetes	0.000145	0.000867	CbGpPWpGaD
Ponatinib—SRC—Signaling by SCF-KIT—FGF2—gestational diabetes	0.000145	0.000866	CbGpPWpGaD
Ponatinib—LCK—Downstream signaling events of B Cell Receptor (BCR)—FGF2—gestational diabetes	0.000143	0.000854	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—LEPR—gestational diabetes	0.000141	0.000843	CbGpPWpGaD
Ponatinib—FGFR2—Signaling by NGF—FGF2—gestational diabetes	0.000138	0.000827	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—GCK—gestational diabetes	0.000136	0.000818	CbGpPWpGaD
Ponatinib—LCK—DAP12 interactions—FGF2—gestational diabetes	0.000136	0.000816	CbGpPWpGaD
Ponatinib—LCK—Fc epsilon receptor (FCERI) signaling—FGF2—gestational diabetes	0.000136	0.000816	CbGpPWpGaD
Ponatinib—LCK—Signaling by FGFR in disease—FGF2—gestational diabetes	0.000136	0.000816	CbGpPWpGaD
Ponatinib—KIT—Signaling by NGF—FGF2—gestational diabetes	0.000136	0.000812	CbGpPWpGaD
Ponatinib—LCK—Signaling by EGFR—FGF2—gestational diabetes	0.000135	0.000808	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—MBL2—gestational diabetes	0.000134	0.000803	CbGpPWpGaD
Ponatinib—LCK—Signaling by EGFR in Cancer—FGF2—gestational diabetes	0.000134	0.000801	CbGpPWpGaD
Ponatinib—LCK—Signaling by PDGF—FGF2—gestational diabetes	0.000133	0.000798	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—MBL2—gestational diabetes	0.000131	0.000786	CbGpPWpGaD
Ponatinib—SRC—Downstream signal transduction—FGF2—gestational diabetes	0.00013	0.000779	CbGpPWpGaD
Ponatinib—SRC—Signaling by FGFR—FGF2—gestational diabetes	0.000129	0.000775	CbGpPWpGaD
Ponatinib—CYP2D6—Biological oxidations—CYP19A1—gestational diabetes	0.000129	0.000775	CbGpPWpGaD
Ponatinib—KIT—Immune System—MBL2—gestational diabetes	0.000129	0.000772	CbGpPWpGaD
Ponatinib—SRC—Signaling by ERBB2—FGF2—gestational diabetes	0.000129	0.000771	CbGpPWpGaD
Ponatinib—FGFR1—Signaling by NGF—FGF2—gestational diabetes	0.000129	0.00077	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling by NGF—FGF2—gestational diabetes	0.000128	0.000768	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—MTNR1B—gestational diabetes	0.000128	0.000765	CbGpPWpGaD
Ponatinib—CYP2D6—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000128	0.000764	CbGpPWpGaD
Ponatinib—ABCG2—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000127	0.00076	CbGpPWpGaD
Ponatinib—LCK—B Cell Activation—FGF2—gestational diabetes	0.000126	0.000755	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—GGCT—gestational diabetes	0.000125	0.000748	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—RBP4—gestational diabetes	0.000124	0.000745	CbGpPWpGaD
Ponatinib—ABCB1—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.000123	0.000736	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—MBL2—gestational diabetes	0.000122	0.000733	CbGpPWpGaD
Ponatinib—FGFR2—Disease—RBP4—gestational diabetes	0.000122	0.000732	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—MBL2—gestational diabetes	0.000122	0.000731	CbGpPWpGaD
Ponatinib—LCK—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000121	0.000722	CbGpPWpGaD
Ponatinib—SRC—Signaling by FGFR in disease—FGF2—gestational diabetes	0.000121	0.000722	CbGpPWpGaD
Ponatinib—KIT—Disease—RBP4—gestational diabetes	0.00012	0.000719	CbGpPWpGaD
Ponatinib—FGFR1—MAPK Signaling Pathway—TNF—gestational diabetes	0.00012	0.000718	CbGpPWpGaD
Ponatinib—SRC—Signaling by EGFR—FGF2—gestational diabetes	0.000119	0.000716	CbGpPWpGaD
Ponatinib—SRC—Signaling by EGFR in Cancer—FGF2—gestational diabetes	0.000118	0.000709	CbGpPWpGaD
Ponatinib—BCR—Disease—FGF2—gestational diabetes	0.000118	0.000707	CbGpPWpGaD
Ponatinib—SRC—Signaling by PDGF—FGF2—gestational diabetes	0.000118	0.000706	CbGpPWpGaD
Ponatinib—FGFR3—Innate Immune System—FGF2—gestational diabetes	0.000114	0.000686	CbGpPWpGaD
Ponatinib—FGFR1—Disease—RBP4—gestational diabetes	0.000114	0.000682	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—RBP4—gestational diabetes	0.000114	0.000681	CbGpPWpGaD
Ponatinib—SRC—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.000113	0.000679	CbGpPWpGaD
Ponatinib—KDR—Developmental Biology—FGF2—gestational diabetes	0.000113	0.000676	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—ADIPOQ—gestational diabetes	0.000112	0.000673	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—MTNR1B—gestational diabetes	0.000111	0.000666	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—LEPR—gestational diabetes	0.000111	0.000665	CbGpPWpGaD
Ponatinib—FGFR3—Adaptive Immune System—FGF2—gestational diabetes	0.00011	0.000658	CbGpPWpGaD
Ponatinib—FGFR2—Disease—NAMPT—gestational diabetes	0.00011	0.000657	CbGpPWpGaD
Ponatinib—FGFR1—Developmental Biology—LEP—gestational diabetes	0.000109	0.000655	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—LEPR—gestational diabetes	0.000109	0.000654	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—GLS2—gestational diabetes	0.000109	0.000653	CbGpPWpGaD
Ponatinib—FGFR2—Disease—GCK—gestational diabetes	0.000109	0.000652	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—LEP—gestational diabetes	0.000109	0.000652	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—RBP4—gestational diabetes	0.000108	0.000649	CbGpPWpGaD
Ponatinib—FGFR1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.000108	0.000648	CbGpPWpGaD
Ponatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.000108	0.000646	CbGpPWpGaD
Ponatinib—KIT—Disease—NAMPT—gestational diabetes	0.000108	0.000645	CbGpPWpGaD
Ponatinib—LYN—Immune System—MBL2—gestational diabetes	0.000108	0.000645	CbGpPWpGaD
Ponatinib—ABL1—Immune System—MBL2—gestational diabetes	0.000107	0.000642	CbGpPWpGaD
Ponatinib—KIT—Disease—GCK—gestational diabetes	0.000107	0.000641	CbGpPWpGaD
Ponatinib—SRC—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000107	0.00064	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—LEPR—gestational diabetes	0.000104	0.00062	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—LEPR—gestational diabetes	0.000103	0.000619	CbGpPWpGaD
Ponatinib—FGFR1—Disease—NAMPT—gestational diabetes	0.000102	0.000612	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—NAMPT—gestational diabetes	0.000102	0.00061	CbGpPWpGaD
Ponatinib—FGFR1—Disease—GCK—gestational diabetes	0.000102	0.000608	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—GCK—gestational diabetes	0.000101	0.000607	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—LEP—gestational diabetes	9.62e-05	0.000576	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—LEP—gestational diabetes	9.58e-05	0.000574	CbGpPWpGaD
Ponatinib—ABL1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	9.47e-05	0.000567	CbGpPWpGaD
Ponatinib—LCK—Signaling by NGF—FGF2—gestational diabetes	9.28e-05	0.000556	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—LEPR—gestational diabetes	9.11e-05	0.000546	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—NAMPT—gestational diabetes	9.04e-05	0.000542	CbGpPWpGaD
Ponatinib—FGFR4—Immune System—FGF2—gestational diabetes	9.01e-05	0.00054	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—GCK—gestational diabetes	8.99e-05	0.000538	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—GGCT—gestational diabetes	8.94e-05	0.000536	CbGpPWpGaD
Ponatinib—LCK—Immune System—MBL2—gestational diabetes	8.82e-05	0.000529	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—MTNR1B—gestational diabetes	8.78e-05	0.000526	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—MTNR1B—gestational diabetes	8.62e-05	0.000517	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—RBP4—gestational diabetes	8.56e-05	0.000513	CbGpPWpGaD
Ponatinib—CYP3A4—Biological oxidations—CYP19A1—gestational diabetes	8.46e-05	0.000507	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—RBP4—gestational diabetes	8.41e-05	0.000503	CbGpPWpGaD
Ponatinib—CYP3A4—Metapathway biotransformation—CYP19A1—gestational diabetes	8.34e-05	0.0005	CbGpPWpGaD
Ponatinib—FGFR4—Disease—FGF2—gestational diabetes	8.32e-05	0.000498	CbGpPWpGaD
Ponatinib—FGFR1—Developmental Biology—FGF2—gestational diabetes	8.31e-05	0.000498	CbGpPWpGaD
Ponatinib—ABCB1—Allograft Rejection—TNF—gestational diabetes	8.28e-05	0.000496	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—FGF2—gestational diabetes	8.27e-05	0.000495	CbGpPWpGaD
Ponatinib—LCK—Disease—RBP4—gestational diabetes	8.21e-05	0.000492	CbGpPWpGaD
Ponatinib—SRC—Signaling by NGF—FGF2—gestational diabetes	8.21e-05	0.000492	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—MTNR1B—gestational diabetes	8.19e-05	0.00049	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—MTNR1B—gestational diabetes	8.16e-05	0.000489	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—RBP4—gestational diabetes	7.98e-05	0.000478	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—RBP4—gestational diabetes	7.96e-05	0.000477	CbGpPWpGaD
Ponatinib—FGFR2—Innate Immune System—FGF2—gestational diabetes	7.87e-05	0.000471	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—GLS2—gestational diabetes	7.82e-05	0.000468	CbGpPWpGaD
Ponatinib—SRC—Immune System—MBL2—gestational diabetes	7.81e-05	0.000468	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—GGCT—gestational diabetes	7.75e-05	0.000464	CbGpPWpGaD
Ponatinib—KIT—Innate Immune System—FGF2—gestational diabetes	7.73e-05	0.000463	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—LEP—gestational diabetes	7.67e-05	0.000459	CbGpPWpGaD
Ponatinib—FGFR2—Adaptive Immune System—FGF2—gestational diabetes	7.56e-05	0.000453	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—LEPR—gestational diabetes	7.47e-05	0.000447	CbGpPWpGaD
Ponatinib—KIT—Adaptive Immune System—FGF2—gestational diabetes	7.42e-05	0.000445	CbGpPWpGaD
Ponatinib—LCK—Disease—NAMPT—gestational diabetes	7.37e-05	0.000441	CbGpPWpGaD
Ponatinib—FGFR1—Innate Immune System—FGF2—gestational diabetes	7.34e-05	0.000439	CbGpPWpGaD
Ponatinib—LCK—Disease—GCK—gestational diabetes	7.32e-05	0.000439	CbGpPWpGaD
Ponatinib—PDGFRA—Innate Immune System—FGF2—gestational diabetes	7.32e-05	0.000438	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—FGF2—gestational diabetes	7.31e-05	0.000438	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—FGF2—gestational diabetes	7.27e-05	0.000436	CbGpPWpGaD
Ponatinib—SRC—Disease—RBP4—gestational diabetes	7.27e-05	0.000436	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—MTNR1B—gestational diabetes	7.2e-05	0.000431	CbGpPWpGaD
Ponatinib—FGFR1—Adaptive Immune System—FGF2—gestational diabetes	7.04e-05	0.000422	CbGpPWpGaD
Ponatinib—PDGFRA—Adaptive Immune System—FGF2—gestational diabetes	7.03e-05	0.000421	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—RBP4—gestational diabetes	7.02e-05	0.00042	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—LEP—gestational diabetes	6.98e-05	0.000418	CbGpPWpGaD
Ponatinib—SRC—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	6.91e-05	0.000414	CbGpPWpGaD
Ponatinib—KDR—Developmental Biology—TNF—gestational diabetes	6.87e-05	0.000412	CbGpPWpGaD
Ponatinib—ABCB1—Transmembrane transport of small molecules—GCK—gestational diabetes	6.86e-05	0.000411	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—GLS2—gestational diabetes	6.77e-05	0.000406	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—GGCT—gestational diabetes	6.75e-05	0.000404	CbGpPWpGaD
Ponatinib—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	6.71e-05	0.000402	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—FGF2—gestational diabetes	6.67e-05	0.000399	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—LEPR—gestational diabetes	6.61e-05	0.000396	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—CYP19A1—gestational diabetes	6.57e-05	0.000394	CbGpPWpGaD
Ponatinib—SRC—Disease—NAMPT—gestational diabetes	6.52e-05	0.000391	CbGpPWpGaD
Ponatinib—SRC—Disease—GCK—gestational diabetes	6.48e-05	0.000388	CbGpPWpGaD
Ponatinib—LYN—Innate Immune System—FGF2—gestational diabetes	6.45e-05	0.000387	CbGpPWpGaD
Ponatinib—ABL1—Innate Immune System—FGF2—gestational diabetes	6.42e-05	0.000385	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—GGCT—gestational diabetes	6.36e-05	0.000381	CbGpPWpGaD
Ponatinib—LYN—Adaptive Immune System—FGF2—gestational diabetes	6.2e-05	0.000371	CbGpPWpGaD
Ponatinib—FGFR3—Disease—FGF2—gestational diabetes	6.15e-05	0.000369	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	6.05e-05	0.000363	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—NAMPT—gestational diabetes	5.98e-05	0.000358	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—GCK—gestational diabetes	5.94e-05	0.000356	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—MTNR1B—gestational diabetes	5.9e-05	0.000354	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—GLS2—gestational diabetes	5.9e-05	0.000353	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—FGF2—gestational diabetes	5.83e-05	0.000349	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—RBP4—gestational diabetes	5.75e-05	0.000345	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—LEP—gestational diabetes	5.67e-05	0.00034	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—GLS2—gestational diabetes	5.56e-05	0.000333	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—FGF2—gestational diabetes	5.3e-05	0.000318	CbGpPWpGaD
Ponatinib—LCK—Innate Immune System—FGF2—gestational diabetes	5.29e-05	0.000317	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—MTNR1B—gestational diabetes	5.23e-05	0.000313	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—RBP4—gestational diabetes	5.09e-05	0.000305	CbGpPWpGaD
Ponatinib—LCK—Adaptive Immune System—FGF2—gestational diabetes	5.08e-05	0.000304	CbGpPWpGaD
Ponatinib—FGFR1—Developmental Biology—TNF—gestational diabetes	5.06e-05	0.000303	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—LEP—gestational diabetes	4.94e-05	0.000296	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—FGF2—gestational diabetes	4.68e-05	0.000281	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—FGF2—gestational diabetes	4.58e-05	0.000275	CbGpPWpGaD
Ponatinib—KIT—Immune System—FGF2—gestational diabetes	4.5e-05	0.00027	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—FGF2—gestational diabetes	4.5e-05	0.000269	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—TNF—gestational diabetes	4.45e-05	0.000267	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—TNF—gestational diabetes	4.43e-05	0.000265	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—CYP19A1—gestational diabetes	4.34e-05	0.00026	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—FGF2—gestational diabetes	4.31e-05	0.000258	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—NAMPT—gestational diabetes	4.28e-05	0.000257	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—FGF2—gestational diabetes	4.27e-05	0.000256	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—FGF2—gestational diabetes	4.26e-05	0.000255	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—GCK—gestational diabetes	4.26e-05	0.000255	CbGpPWpGaD
Ponatinib—FGFR2—Disease—FGF2—gestational diabetes	4.23e-05	0.000254	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—GGCT—gestational diabetes	4.16e-05	0.000249	CbGpPWpGaD
Ponatinib—KIT—Disease—FGF2—gestational diabetes	4.16e-05	0.000249	CbGpPWpGaD
Ponatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	4.09e-05	0.000245	CbGpPWpGaD
Ponatinib—FGFR1—Disease—FGF2—gestational diabetes	3.95e-05	0.000236	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—FGF2—gestational diabetes	3.93e-05	0.000236	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—LEP—gestational diabetes	3.9e-05	0.000234	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—LEP—gestational diabetes	3.83e-05	0.00023	CbGpPWpGaD
Ponatinib—LYN—Immune System—FGF2—gestational diabetes	3.76e-05	0.000225	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—FGF2—gestational diabetes	3.75e-05	0.000225	CbGpPWpGaD
Ponatinib—ABL1—Immune System—FGF2—gestational diabetes	3.74e-05	0.000224	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—NAMPT—gestational diabetes	3.71e-05	0.000222	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—GCK—gestational diabetes	3.69e-05	0.000221	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—LEP—gestational diabetes	3.64e-05	0.000218	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—GLS2—gestational diabetes	3.63e-05	0.000218	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—LEP—gestational diabetes	3.63e-05	0.000217	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—NAMPT—gestational diabetes	3.23e-05	0.000194	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—TNF—gestational diabetes	3.23e-05	0.000193	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—GCK—gestational diabetes	3.21e-05	0.000192	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—LEP—gestational diabetes	3.2e-05	0.000192	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—CYP19A1—gestational diabetes	3.11e-05	0.000186	CbGpPWpGaD
Ponatinib—LCK—Immune System—FGF2—gestational diabetes	3.08e-05	0.000185	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—NAMPT—gestational diabetes	3.05e-05	0.000182	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—GCK—gestational diabetes	3.03e-05	0.000181	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—FGF2—gestational diabetes	2.96e-05	0.000178	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—FGF2—gestational diabetes	2.91e-05	0.000174	CbGpPWpGaD
Ponatinib—LCK—Disease—FGF2—gestational diabetes	2.84e-05	0.00017	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—FGF2—gestational diabetes	2.76e-05	0.000165	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—FGF2—gestational diabetes	2.76e-05	0.000165	CbGpPWpGaD
Ponatinib—SRC—Immune System—FGF2—gestational diabetes	2.73e-05	0.000163	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—CYP19A1—gestational diabetes	2.7e-05	0.000161	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—LEP—gestational diabetes	2.62e-05	0.000157	CbGpPWpGaD
Ponatinib—SRC—Disease—FGF2—gestational diabetes	2.52e-05	0.000151	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—FGF2—gestational diabetes	2.43e-05	0.000146	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—CYP19A1—gestational diabetes	2.35e-05	0.000141	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—LEP—gestational diabetes	2.32e-05	0.000139	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—CYP19A1—gestational diabetes	2.21e-05	0.000133	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—FGF2—gestational diabetes	1.99e-05	0.000119	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—NAMPT—gestational diabetes	1.99e-05	0.000119	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—GCK—gestational diabetes	1.98e-05	0.000119	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—FGF2—gestational diabetes	1.76e-05	0.000106	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CYP19A1—gestational diabetes	1.45e-05	8.67e-05	CbGpPWpGaD
